Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Current Opinion in Genetics & Development|March 11, 1999
CDK inhibition and cancer therapyM D Garrett, A FattaeyGenes & Development|April 1, 1997
New functional activities for the p21 family of CDK inhibitorsJ LaBaer, M D Garrett, L F Stevenson, et al.Progress in Cell Cycle Research|January 1, 1997
Myt1: a Wee1-type kinase that phosphorylates Cdc2 on residue Thr14A Fattaey, R N BooherPhilosophical Transactions of the Royal Society of London. Series B, Biological Sciences|June 29, 1993
Transcriptional inhibition by the retinoblastoma proteinA Fattaey, K Helin, E HarlowMolecular and Cellular Biology|October 1, 1993
Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma proteinK Helin, E Harlow, A FattaeyThe Journal of Biological Chemistry|March 30, 2001
Cell cycle and biochemical effects of PD 0183812. A potent inhibitor of the cyclin D-dependent kinases CDK4 and CDK6D W Fry, D C Bedford, P H Harvey, et al.Avian Diseases|July 1, 1992
Production and characterization of monoclonal antibodies to budgerigar fledgling disease virus major capsid protein VPA Fattaey, L Lenz, R A ConsigliThe Journal of Biological Chemistry|August 29, 1997
Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activityR N Booher, P S Holman, A FattaeyThe Journal of Clinical Psychiatry|February 1, 1985
Use of ECT in a depressed hypothyroid patientM D GarrettJournal of Virology|April 5, 2001
Analyses of single-amino-acid substitution mutants of adenovirus type 5 E1B-55K proteinY Shen, G Kitzes, J A Nye, et al.Pageof 3